1-4 of 4
Junko Ohkanda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Farnesyltransferase and geranylgeranyltransferase I inhibitors stimulate RhoB transcription by inducing HDAC1 dissociation and promoting histone acetylation of the RhoB promotor

Frederic Delarue, Jalila Adnane, James Hawker, Francisco Bizouarn, Junko Ohkanda, Michelle Blaskovich, Kuichun Zhu, Andrew D. Hamilton, Srikumar Chellappan, Said M. Sebti
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1404.
Published: 01 May 2005
View article titled, Farnesyltransferase and geranylgeranyltransferase I inhibitors stimulate RhoB transcription by inducing HDAC1 dissociation and promoting histone acetylation of the RhoB promotor
Journal Articles

Geranylgeranyltransferase i inhibitor, GGTI-2154, induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice

Jiazhi Sun, Junko Ohkanda, Domenico Coppola, Hang Yin, Mohit Kothare, Brian Busiglio, Andrew D. Hamilton, Said M. Sebti
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 893.
Published: 01 April 2004
View article titled, Geranylgeranyltransferase i inhibitor, GGTI-2154, induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice
Journal Articles

Geranylgeranyltransferase I Inhibitor GGTI-2154 Induces Breast Carcinoma Apoptosis and Tumor Regression in H-Ras Transgenic Mice

Jiazhi Sun, Junko Ohkanda, Domenico Coppola, Hang Yin, Mohit Kothare, Brian Busciglio, Andrew D. Hamilton, Saïd M. Sebti
Journal: Cancer Research
Cancer Res (2003) 63 (24): 8922–8929.
Published: 24 December 2003
View article titled, Geranylgeranyltransferase I Inhibitor GGTI-2154 Induces Breast Carcinoma Apoptosis and Tumor Regression in H-Ras Transgenic Mice
Open the PDF for Geranylgeranyltransferase I Inhibitor GGTI-2154 Induces Breast Carcinoma Apoptosis and Tumor Regression in H-Ras Transgenic Mice in another window
Journal Articles

Antitumor Efficacy of a Novel Class of Non-thiol-containing Peptidomimetic Inhibitors of Farnesyltransferase and Geranylgeranyltransferase I: Combination Therapy with the Cytotoxic Agents Cisplatin, Taxol, and Gemcitabine

Jiazhi Sun, Michelle A. Blaskovich, David Knowles, Yimin Qian, Junko Ohkanda, Ratna D. Bailey, Andrew D. Hamilton, Saïd M. Sebti
Journal: Cancer Research
Cancer Res (1999) 59 (19): 4919–4926.
Published: 01 October 1999
View article titled, Antitumor Efficacy of a Novel Class of Non-thiol-containing Peptidomimetic Inhibitors of Farnesyltransferase and Geranylgeranyltransferase I: <subtitle>Combination Therapy with the Cytotoxic Agents Cisplatin, Taxol, and Gemcitabine</subtitle>
Open the PDF for Antitumor Efficacy of a Novel Class of Non-thiol-containing Peptidomimetic Inhibitors of Farnesyltransferase and Geranylgeranyltransferase I: <subtitle>Combination Therapy with the Cytotoxic Agents Cisplatin, Taxol, and Gemcitabine</subtitle> in another window